The novel therapy of tirzepatide peptide represents a significant development in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment